MAHA Splits With Trump Admin Over Key Issues
The Trump administration is experiencing internal conflict with Health and Human Services Secretary Robert F. Kennedy Jr. and his 'Make America Healthy Again' (MAHA) movement over key policy decisions, including the surgeon general nomination and pesticide regulations in the Farm Bill. The rift intensified when Trump nominated Nicole Saphier over MAHA-backed Casey Means, drawing criticism from MAHA supporters who view the move as a broken promise. Disagreements over agricultural policy and public health priorities are deepening divisions within the Republican Party ahead of the midterms.
- ▪HHS Secretary Robert F. Kennedy Jr. expressed dissatisfaction with certain Trump administration policies, particularly on pesticides, despite publicly supporting the president.
- ▪President Trump nominated Nicole Saphier as surgeon general after Casey Means failed to secure enough Republican support, with Senator Bill Cassidy opposing Means over her vaccination views.
- ▪MAHA activists, including Alex Clark and Vani Hari, criticized Saphier's nomination, calling it a betrayal and demanding medical freedom.
- ▪The Farm Bill, H.R.7567, sparked GOP infighting over pesticide regulation, conservation measures, and changes to the SNAP program.
- ▪White House spokesman Kush Desai defended Saphier, stating she would advance the administration's MAHA agenda.
Opening excerpt (first ~120 words) tap to expand
By Jasmine LawsUS News ReporterShareNewsweek is a Trust Project memberSee more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.The Trump administration has been clashing with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and those aligned with his 'Make America Healthy Again' (MAHA) campaign over a number of key issues in recent weeks, causing tension and infighting in the GOP, threatening its future agenda.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Newsweek.
Discussion
0 commentsMore from Newsweek
